ID   XP3OS
AC   CVCL_3245
AS   CVCL_F511
SY   XP30S; GM04314
DR   CLO; CLO_0019557
DR   Coriell; GM04314
DR   JCRB; JCRB0303
DR   JCRB; KURB1002
DR   JCRB; KURB1003
DR   JCRB; KURB1004
RX   PubMed=1372102;
ST   Source(s): JCRB
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
CA   Finite cell line
//
ID   1-5c-4
AC   CVCL_2260
SY   Clone 1-5c-4; Clone 1-5c-4 WKD of Chang Conjunctiva; Wong-Kilbourne derivative of Chang conjunctiva; ChWK
DR   CLO; CLO_0002500
DR   CLO; CLO_0002501
DR   CLDB; cl793
DR   CLDB; cl794
DR   CLDB; cl795
DR   ATCC; CCL-20.2
DR   BioSample; SAMN03151673
DR   ECACC; 88021103
DR   IZSLER; BS CL 93
DR   KCLB; 10020.2
RX   PubMed=566722;
RX   PubMed=19630270;
RX   PubMed=20143388;
WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v7_2.pdf
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed 566722, PubMed 20143388).
CC   Omics: Transcriptome analysis.
ST   Source(s): ATCC; KCLB
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   FGA: 18,21
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C4029; Cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0030 ! HeLa
SX   Female
CA   Cancer cell line
//
